Fibroblast growth factor-2 stimulates endothelial nitric oxide synthase expression and inhibits apoptosis by a nitric oxide-dependent pathway in Nb2 lymphoma cells

Endocrinology

Volumn 142, Issue 1, 2001, Pages 81-88

  Murphy, Paul R ^a   Limoges, Mireille ^a   Dodd, Faith ^a   Boudreau, Robert T M ^a   Too, Catherine K L ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; FIBROBLAST GROWTH FACTOR 2; NITRIC OXIDE SYNTHASE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL PROTECTION; CELL STIMULATION; GENE TARGETING; HUMAN; HUMAN CELL; LYMPHOMA CELL; MACROPHAGE ACTIVATION; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; RECEPTOR AFFINITY; TUMOR GROWTH;

EID: 0035117673     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.1.7866     Document Type: Article

References (47)

1. The FGF family of growth factors and oncogenes
2. Interaction of fibroblast growth factor (FGF) with megakaryocytopoiesis and demonstration of FGF receptor expression in megakaryocytes and megakaryocytic-like cells
3. T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: A potential pathologic role
4. + T cells
5. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia
6. Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine
7. Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis
8. Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro
9. Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo
10. Interferon γ inhibits apoptotic cell death in B cell chronic lymphocytic leukemia
11. nrb-related mRNA in rat lymphoma cells
12. L-Arginine inhibits apoptosis via an NO-dependent mechanism in Nb2 lymphoma cells
13. + exchange in rat Nb2 node lymphoma cells. Stimulation by 12-O-tetradecanoyl-phorbol-13-acetate
14. Decline in basic fibroblast growth factor (FGF-2) mRNA expression in female rat hypothalamus at puberty
15. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation
16. Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax, by prolactin in rat Nb2 lymphoma cells
17. Prolactin-regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expression
18. Role of Bag-1 in the survival and proliferation of the cytokine-dependent lymphocyte lines, Ba/F3 and Nb2
19. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
20. Nitric oxide as a bifunctional regulator of apoptosis
21. Nitric oxide and apoptosis
22. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation
23. Nitric oxide induces apoptosis in mouse thymocytes
24. The nitric oxide donors, azide and hydroxylamine, inhibit the programmed cell death of cytokine-deprived human eosinophils
25. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels
26. Nitric oxide fully protects against UVA-induced apoptosis in tight correlation with Bcl-2 up-regulation
27. Prolactin, growth hormone, and insulin-like growth factor-I in the immune system
28. The transcription factor Pit-1/GHF-1 is expressed in hemopoietic and lymphoid tissues
29. Human thymocytes express a prolactin-like messenger ribonucleic acid and synthesize bioactive prolactin-like proteins
30. Expression of prolactin and its receptor in human lymphoid cells
31. Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytofluorometry
32. Prolactin receptor gene expression in lymphoid cells
33. The rat Nb2 lymphoma: A novel model for tumor progression
34. Investigation of intracellular signals mediating the anti-apoptotic action of prolactin in Nb2 lymphoma cells
35. Comparison of glucocorticoid-induced effects in prolactin-dependent and autonomous rat Nb2 lymphoma cells
36. +-ATPase
37. Nuclear activities of basic fibroblast growth factor: Potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals
38. Basic fibroblast growth factor increases nitric oxide synthase production in bovine endothelial cells
39. 6-Mercaptopurine decreases the Bcl-2/Bax ratio and induces apoptosis in activated splenic B lymphocytes
40. K-sam-related gene, N-sam, encodes fibroblast growth factor receptor and is expressed in T-lymphocytic tumors
41. A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma
42. Hypotensive activity of fibroblast growth factor
43. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries
44. Pregnancy augments uteroplacental vascular endothelial growth factor gene expression and vasodilator effects
45. Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor- and epidermal growth factor-stimulated expression of endothelial nitric oxide synthase in ovine fetoplacental artery endothelial cells
46. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine
47. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase